Allspring Global Investments Holdings, LLC Ligand Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 115,480 shares of LGND stock, worth $14.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

115,480

Previous 99,034 16.61%

Holding current value

$14.2 Million

Previous $8.34 Million 38.63%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$82.7 - $110.11 $1.36 Million - $1.81 Million	16,446 Added 16.61%	115,480 $11.6 Million
Q2 2024 Jul 26, 2024	BUY	$68.53 - $87.91 $948,386 - $1.22 Million	13,839 Added 16.24%	99,034 $8.34 Million
Q1 2024 Apr 18, 2024	BUY	$68.64 - $89.2 $3.3 Million - $4.28 Million	48,022 Added 129.19%	85,195 $6.23 Million
Q4 2023 Jan 25, 2024	BUY	$49.57 - $72.63 $915,657 - $1.34 Million	18,472 Added 98.78%	37,173 $2.65 Million
Q3 2023 Oct 27, 2023	BUY	$58.86 - $72.67 $1.1 Million - $1.36 Million	18,701 New	18,701 $1.12 Million
Q2 2023 Jul 18, 2023	BUY	$69.53 - $79.33 $3.59 Million - $4.1 Million	51,639 Added 663.06%	59,427 $4.28 Million
Q1 2023 Apr 13, 2023	SELL	$65.67 - $77.08 $1.39 Million - $1.63 Million	-21,194 Reduced 73.13%	7,788 $572,000
Q4 2022 Jan 23, 2023	BUY	$61.72 - $96.74 $1.62 Million - $2.55 Million	26,316 Added 987.1%	28,982 $0
Q3 2022 Oct 26, 2022	BUY	$0.01 - $107.56 $7 - $77,873	724 Added 37.28%	2,666 $229,000
Q2 2022 Jul 25, 2022	SELL	$74.52 - $117.06 $804,890 - $1.26 Million	-10,801 Reduced 84.76%	1,942 $173,000
Q1 2022 May 02, 2022	SELL	$94.99 - $151.56 $527,669 - $841,915	-5,555 Reduced 30.36%	12,743 $1.43 Million
Q4 2021 Jan 28, 2022	BUY	$127.69 - $165.85 $2.34 Million - $3.03 Million	18,298 New	18,298 $2.83 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Ligand Pharmaceuticals Inc Transaction History